Economic burden of diabetic foot ulcer: a case of Iran.
Cost
Diabetic foot
Economic burden
Iran
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
21 Mar 2024
21 Mar 2024
Historique:
received:
20
05
2023
accepted:
15
03
2024
medline:
22
3
2024
pubmed:
22
3
2024
entrez:
22
3
2024
Statut:
epublish
Résumé
Diabetic foot ulcer (DFU) is known as a serious complication of diabetes mellitus in patients with diabetes, imposing heavy medical costs on healthcare systems due to its chronic nature. patients with severe diabetic foot ulcer are often disabled to work, and some of them may even die, leading to associated productivity losses. Since no previous study has investigated the economic burden of DFU in Iran, this study is to estimate the economic burden of diabetic foot disease in Iran. In this descriptive cross-sectional study, randomly selected samples consisted of 542 patients with DFU, hospitalized in the hospitals of Shahid Beheshti University of Medical Sciences. The demographic profile and cost data used in this analysis were derived from a researcher-designed checklist. Lost productivity was calculated based on Human Capital Approach, and the total economic cost of DFU was determined using patient-level data on costs and prevalence data from the global burden of diseases reports. All analyses were performed using SPSS software (Version 23), and Microsoft Excel (Version 19). The economic burden of DFU in Iran in two scenarios of discounting future costs and not discounting them was about $8.7 billion and $35 billion, respectively (about 0.59 and 2.41% of GDP). 79.25% of the estimated costs in this study were indirect costs and productivity losses, of which 99.34% (7,918.4 million Dollars) were productivity losses due to premature death. 20.75% (2,064.4 million dollars) of the estimated costs in this study were direct costs. The average length of stay (LOS) was 8.10 days (SD = 9.32), and 73.3% of patients recovered and were discharged after hospitalization and 7.6% died. The majority of the costs are imposed on the age group of 60-69 year (53.42% of the productivity lost due to hospital length of stay, 58.91% of the productivity lost due to premature death & 40.41% of direct costs). DFU represents a heavy burden to patients, Iran's health system, and the economy. Early prevention strategies need to be prioritized in making public health policies. These policies and decisions can be in the area of changing lifestyle, health education, changing people's behavior, and encouraging physical activity that targeted high-risk populations in order to reduce the prevalence of diabetic foot and resulting substantial economic burden.
Sections du résumé
BACKGROUND
BACKGROUND
Diabetic foot ulcer (DFU) is known as a serious complication of diabetes mellitus in patients with diabetes, imposing heavy medical costs on healthcare systems due to its chronic nature. patients with severe diabetic foot ulcer are often disabled to work, and some of them may even die, leading to associated productivity losses. Since no previous study has investigated the economic burden of DFU in Iran, this study is to estimate the economic burden of diabetic foot disease in Iran.
METHODS
METHODS
In this descriptive cross-sectional study, randomly selected samples consisted of 542 patients with DFU, hospitalized in the hospitals of Shahid Beheshti University of Medical Sciences. The demographic profile and cost data used in this analysis were derived from a researcher-designed checklist. Lost productivity was calculated based on Human Capital Approach, and the total economic cost of DFU was determined using patient-level data on costs and prevalence data from the global burden of diseases reports. All analyses were performed using SPSS software (Version 23), and Microsoft Excel (Version 19).
RESULTS
RESULTS
The economic burden of DFU in Iran in two scenarios of discounting future costs and not discounting them was about $8.7 billion and $35 billion, respectively (about 0.59 and 2.41% of GDP). 79.25% of the estimated costs in this study were indirect costs and productivity losses, of which 99.34% (7,918.4 million Dollars) were productivity losses due to premature death. 20.75% (2,064.4 million dollars) of the estimated costs in this study were direct costs. The average length of stay (LOS) was 8.10 days (SD = 9.32), and 73.3% of patients recovered and were discharged after hospitalization and 7.6% died. The majority of the costs are imposed on the age group of 60-69 year (53.42% of the productivity lost due to hospital length of stay, 58.91% of the productivity lost due to premature death & 40.41% of direct costs).
CONCLUSIONS
CONCLUSIONS
DFU represents a heavy burden to patients, Iran's health system, and the economy. Early prevention strategies need to be prioritized in making public health policies. These policies and decisions can be in the area of changing lifestyle, health education, changing people's behavior, and encouraging physical activity that targeted high-risk populations in order to reduce the prevalence of diabetic foot and resulting substantial economic burden.
Identifiants
pubmed: 38515182
doi: 10.1186/s12913-024-10873-9
pii: 10.1186/s12913-024-10873-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
363Informations de copyright
© 2024. The Author(s).
Références
Mirzaei M, Rahmaninan M, Mirzaei M, Nadjarzadeh A, Dehghani Tafti AA. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study. BMC Public Health. 2020;20:1–9.
doi: 10.1186/s12889-020-8267-y
Mariam TG, Alemayehu A, Tesfaye E, Mequannt W, Temesgen K, Yetwale F, et al. Prevalence of diabetic foot ulcer and associated factors among adult diabetic patients who attend the diabetic follow-up clinic at the University of Gondar Referral Hospital, North West Ethiopia, 2016: institutional-based cross-sectional study. J Diabetes Res. 2017;2017:2879249. https://doi.org/10.1155/2017/2879249 .
Lu Q, Wang J, Wei X, Wang G, Xu Y, Lu Z, et al. Cost of diabetic foot ulcer management in China: a 7-year single-center retrospective review. Diabetes Metab Syndr Obes. 2020;13:4249–60.
pubmed: 33204131
pmcid: 7667006
doi: 10.2147/DMSO.S275814
Nasli-Esfahani E, Farzadfar F, Kouhnavard M, Ghodssi-Ghassemabadi R, Khajavi A, Peimani M, et al. Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran. J Diabetes Metab Disord. 2017;16:1–8.
doi: 10.1186/s40200-017-0291-9
Toscano CM, Sugita TH, Rosa MQ, Pedrosa HC, Rosa RdS, Bahia LR. Annual direct medical costs of diabetic foot disease in Brazil: a cost of illness study. Int J Environ Res Public Health. 2018;15(1):89.
pubmed: 29316689
pmcid: 5800188
doi: 10.3390/ijerph15010089
Woods T-J, Tesfay F, Speck P, Kaambwa B. Economic evaluations considering costs and outcomes of diabetic foot ulcer infections: a systematic review. PLoS One. 2020;15(4):e0232395.
pubmed: 32353082
pmcid: 7192475
doi: 10.1371/journal.pone.0232395
Rastogi A, Goyal G, Kesavan R, Bal A, Kumar H, Kamath P, et al. Long term outcomes after incident diabetic foot ulcer: Multicenter large cohort prospective study (EDI-FOCUS investigators) epidemiology of diabetic foot complications study: epidemiology of diabetic foot complications study. Diabetes Res Clin Pract. 2020;162:108113.
pubmed: 32165163
doi: 10.1016/j.diabres.2020.108113
Ahmadishooli A, Davoodian P, Shoja S, Ahmadishooli B, Dadvand H, Hamadiyan H, et al. Frequency and antimicrobial susceptibility patterns of diabetic foot infection of patients from Bandar Abbas District. Southern Iran J Pathog. 2020;2020:1057167.
pubmed: 32566310
Asadi-Samani M, Moradi M-T, Mahmoodnia L, Alaei S, Asadi-Samani F, Luther T. Traditional uses of medicinal plants to prevent and treat diabetes; an updated review of ethnobotanical studies in Iran. J Nephropathol. 2017;6(3):118.
pubmed: 28975089
pmcid: 5607970
doi: 10.15171/jnp.2017.20
Muhammad FY, Pedro LM, Suleiman HH, Uloko AE, Gezawa ID, Adenike E, et al. Cost of illness of diabetic foot ulcer in a resource limited setting: a study from Northwestern Nigeria. J Diabetes Metab Disord. 2018;17:93–9.
pubmed: 30918841
pmcid: 6405375
doi: 10.1007/s40200-018-0344-8
Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020;13(1):1–4.
pubmed: 31956341
pmcid: 6958592
doi: 10.1186/s13047-020-00383-2
Kerr M, Barron E, Chadwick P, Evans T, Kong W, Rayman G, et al. The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabet Med. 2019;36(8):995–1002.
pubmed: 31004370
doi: 10.1111/dme.13973
Yazdanpanah L, Shahbazian H, Nazari I, Arti HR, Ahmadi F, Mohammadianinejad SE, et al. Prevalence and related risk factors of diabetic foot ulcer in Ahvaz, south west of Iran. Diabetes Metab Syndr. 2018;12(4):519–24.
pubmed: 29602761
doi: 10.1016/j.dsx.2018.03.018
Mahmoodi H, Abdi K, Navarro-Flores E, Karimi Z, Sharif Nia H, Gheshlagh RG. Psychometric evaluation of the Persian version of the diabetic foot self-care questionnaire in Iranian patients with diabetes. BMC Endocr Disord. 2021;21(1):72.
pubmed: 33865367
pmcid: 8052781
doi: 10.1186/s12902-021-00734-5
Javanbakht M, Baradaran HR, Mashayekhi A, Haghdoost AA, Khamseh ME, Kharazmi E, et al. Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PLoS One. 2011;6(10):e26864.
pubmed: 22066013
pmcid: 3204988
doi: 10.1371/journal.pone.0026864
Aalaa M, Sanjari M, Mohajeri-Tehrani MR, Mehrdad N, Amini MR. A multidisciplinary team approach in Iranian diabetic foot research group. J Diabetes Metab Disord. 2019;18:721–3.
pubmed: 31890696
pmcid: 6915241
doi: 10.1007/s40200-019-00450-x
Lo ZJ, Lim X, Eng D, Car J, Hong Q, Yong E, et al. Clinical and economic burden of wound care in the tropics: a 5-year institutional population health review. Int Wound J. 2020;17(3):790–803.
pubmed: 32149471
pmcid: 7948834
doi: 10.1111/iwj.13333
Öien R, Ragnarson TG. Accurate diagnosis and effective treatment of leg ulcers reduce prevalence, care time and costs. J Wound Care. 2006;15(6):259–62.
pubmed: 16802562
doi: 10.12968/jowc.2006.15.6.26922
Costa N, Derumeaux H, Rapp T, Garnault V, Ferlicoq L, Gillette S, et al. Methodological considerations in cost of illness studies on Alzheimer disease. Heal Econ Rev. 2012;2(1):18.
doi: 10.1186/2191-1991-2-18
Afkar A, Jalilian H, Pourreza A, Mir H, Sigaroudi AE, Heydari S. Cost analysis of breast cancer: a comparison between private and public hospitals in Iran. BMC Health Serv Res. 2021;21(1):1–11.
doi: 10.1186/s12913-021-06136-6
Yousefi M, Assari Arani A, Sahabi B, Kazemnejad A, Fazaeli S. Household health costs: direct, indirect and Intangible. Iran J Public Health. 2014;43(2):202–9.
pubmed: 26060744
pmcid: 4450688
Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Disease and Injury Burden 1990–2019 Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME). 2020. Available from: https://vizhub.healthdata.org/gbd-results/ .
Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106–16.
pubmed: 27585063
doi: 10.1080/07853890.2016.1231932
Khalooei A, Meymand MM. Frequency of diabetes foot ulcer and related factors among adult diabetic patients in the diabetes center of Kerman, Iran. Shiraz E-Med J. 2020;21(1):e90082. https://doi.org/10.5812/semj.90082 .
Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327–37.
pubmed: 25548737
pmcid: 4278062
doi: 10.3350/cmh.2014.20.4.327
World Health Organization. Life tables by country (GHE: Life tables). 2023. Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/gho-ghe-life-tables-by-country .
STAtistical Center of Iran(SCI). Labor force and population data. 2023. Available from: https://www.amar.org.ir .
Ministry of Cooperation LaSW. Statistical yearbook of the Statistical yearbook of the Ministry of Cooperation, Labor and Social Welfare for 2021 for 2021. 2022. Available from: https://ketab.ir/book/95a2ea91-3cc9-4e37-ab92-dbbf478b794c .
Xie F, Thumboo J, Fong K-Y, Lo N-N, Yeo S-J, Yang K-Y, et al. A study on indirect and intangible costs for patients with knee osteoarthritis in Singapore. Value in Health. 2008;11(s1):S84–90.
pubmed: 18387072
doi: 10.1111/j.1524-4733.2008.00371.x
World Bnk. GDP, PPP (current international $) - Iran, Islamic Rep. 2023. Available from: https://data.worldbank.org/indicator/NY.GDP.MKTP.PP.CD?locations=IR .
Jalilian H, Heydari S, Imani A, Salimi M, Mir N, Najafipour F. Economic burden of type 2 diabetes in Iran: a cost-of-illness study. Health Sci Rep. 2023;6(2):e1120.
pubmed: 36824619
pmcid: 9941092
doi: 10.1002/hsr2.1120
Jeyaraman K, Berhane T, Hamilton M, Chandra AP, Falhammar H. Mortality in patients with diabetic foot ulcer: a retrospective study of 513 cases from a single Centre in the Northern Territory of Australia. BMC Endocr Disord. 2019;19(1):1.
pubmed: 30606164
pmcid: 6318899
doi: 10.1186/s12902-018-0327-2
Jupiter DC, Thorud JC, Buckley CJ, Shibuya N. The impact of foot ulceration and amputation on mortality in diabetic patients I.: from ulceration to death, a systematic review. Int Wound J. 2016;13(5):892–903.
pubmed: 25601358
doi: 10.1111/iwj.12404
Chen L, Sun S, Gao Y, Ran X. Global mortality of diabetic foot ulcer: a systematic review and meta-analysis of observational studies. Diabetes Obes Metab. 2023;25(1):36–45.
pubmed: 36054820
doi: 10.1111/dom.14840
Davari M, Boroumand Z, Amini M, Aslani A, Hosseini M. The direct medical costs of outpatient cares of type 2 diabetes in Iran: a retrospective study. Int J Prev Med. 2016;7:72.
pubmed: 27217937
pmcid: 4872475
doi: 10.4103/2008-7802.181758
Rahimitabar P, Kraemer A, Bozorgmehr K, Ebrahimi F, Takian A. Health condition of Afghan refugees residing in Iran in comparison to Germany: a systematic review of empirical studies. Int J Equity Health. 2023;22(1):16.
pubmed: 36681845
pmcid: 9862781
doi: 10.1186/s12939-023-01832-7
Statistical Center of Iran(SCI). Iran statistical yearbook 2019–2020: population. 2023. Available from: https://www.amar.org.ir/english/Iran-Statistical-Yearbook/Iran-Statistical-Yearbook-2019-2020 .
United Nations Refugee Agency. Refugees in Iran. 2023. Available from: https://www.unhcr.org/ir/refugees-in-iran/ .
Mir H, Seyednejad F, Jalilian H, Nosratnejad S, Yousefi M. Cost of lung cancer in East Azerbaijan province, in Iran, in 2017. Int J Pharm Healthc Mark. 2020;14(3):461–70.
doi: 10.1108/IJPHM-08-2019-0055
Zarei E, Madarshahian E, Nikkhah A, Khodakarim S. Incidence of pressure ulcers in intensive care units and direct costs of treatment: Evidence from Iran. J Tissue Viability. 2019;28(2):70–4.
pubmed: 30795879
doi: 10.1016/j.jtv.2019.02.001
Kiadaliri AA, Najafi B, Mirmalek-Sani M. Quality of life in people with diabetes: a systematic review of studies in Iran. J Diabetes Metab Disord. 2013;12(1):54.
pubmed: 24354933
pmcid: 7968439
doi: 10.1186/2251-6581-12-54
Kapur A. Economic analysis of diabetes care. Indian J Med Res. 2007;125(3):473–82.
pubmed: 17496369
Esteghamati A, Khalilzadeh O, Anvari M, Meysamie A, Abbasi M, Forouzanfar M, et al. The economic costs of diabetes: a population-based study in Tehran. Iran Diabetologia. 2009;52:1520–7.
pubmed: 19475364
doi: 10.1007/s00125-009-1398-4
Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA, et al. Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36:e3266.
pubmed: 32176447
doi: 10.1002/dmrr.3266
Lim JZM, Ng NSL, Thomas C. Prevention and treatment of diabetic foot ulcers. J R Soc Med. 2017;110(3):104–9.
pubmed: 28116957
pmcid: 5349377
doi: 10.1177/0141076816688346
Alberti KGMM, Zimmet P, Shaw J. International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med. 2007;24(5):451–63.
pubmed: 17470191
doi: 10.1111/j.1464-5491.2007.02157.x
Bergman M, Buysschaert M, Schwarz PE, Albright A, Narayan KV, Yach D. Diabetes prevention: global health policy and perspectives from the ground. Diabetes Manag (Lond). 2012;2(4):309–21.
pubmed: 26339296
doi: 10.2217/dmt.12.34
Bonnet J-B, Sultan A. Social deprivation, healthcare access and diabetic foot ulcer: a narrative review. J Clin Med. 2022;11(18):5431.
pubmed: 36143078
pmcid: 9501414
doi: 10.3390/jcm11185431
Bruno MT, Scalia G, Cassaro N, Costanzo M, Boemi S. Conservative management of CIN2p16 positive lesions in women with multiple HPV infection. 2020.
Gong H-Z, Han C, Yang F-L, Wang C-F, Wang J-L, Wang M-S. Treatment delay in childhood pleural tuberculosis and associated factors. BMC Infect Dis. 2020;20(1):1–7.
doi: 10.1186/s12879-020-05496-4